X4 Pharmaceuticals Statistics
NASDAQ: XFORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.00+0.04 (+1.35%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
X4 Pharmaceuticals by the numbers
X4 Pharmaceuticals has a market capitalization of $306.3 million based on 102.11M shares outstanding. Its trailing P/E ratio is 5.5. The stock trades 2.8% below its 50-day average and 20.1% below its 200-day average.
Average daily trading volume is 877.70K shares, or about $2.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XFOR valuation vs. peer median
| Metric | XFOR | Peer median | Difference |
|---|---|---|---|
| Market cap | $306.34M | $276.29M | +11% |
| Avg. volume | 877.70K | 593.54K | +48% |
Peer median across 8 companies: TRXB, SLBT, DTIL, CCCC, AGEN, KYTX, AGMB, OCGN.
Valuation
- Market cap
- $306.34M
- P/E (TTM)
- 5.45
- Price / sales (latest FY)
- 47.13
- EPS (TTM)
- $0.55
- Shares outstanding
- 102.11M
Price and trading
- Previous close
- 2.96
- Open
- 2.93
- Day range
- 2.89 – 3.06
- 52-week range
- 2.43 – 4.83
- 52-week change
- -20.00%
- Beta
- —
- Volume
- 1.83M
- Average volume
- 877.70K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 306.34M
- Pe
- 5.45
- Forward Pe
- -3.85
- Eps
- 0.55
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.83
- Week52 Low
- 2.43
- Avg Volume
- 877.70K
- Shares Outstanding
- 102.11M
- Ma50
- 3.09
- Ma200
- 3.76
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -37.89%
- Pct From52w Low
- 23.46%